Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Smolen

Showing results (841-850 of 1,467) with videos related to

Pageof 147
Sort By:
Genes & Development|August 5, 2009
A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progressionMin Yu, Gromoslaw A Smolen, Jianmin Zhang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 1, 2007
Development, validation, and application of a microsimulation model to predict stroke and mortality in medically managed asymptomatic patients with significant carotid artery stenosisHarry J Smolen, David J Cohen, Gregory P Samsa, et al.
Molecular Pharmaceutics|March 21, 2013
In vivo gene delivery with L-tyrosine polyphosphate nanoparticlesAndrew J Ditto, John J Reho, Kush N Shah, et al.
Annals of the Rheumatic Diseases|May 21, 2008
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rateG Wells, J-C Becker, J Teng, et al.
The Journal of Investigative Dermatology|August 1, 1996
Immunoglobulin E response to human proteins in atopic patientsR Valenta, D Maurer, R Steiner, et al.
Journal of Proteome Research|October 6, 2022
A Parallelization Strategy for the Time Efficient Analysis of Thousands of LC/MS Runs in High-Performance Computing EnvironmentPatrick van Zalm, Arthur Viodé, Kinga Smolen, et al.
Arthritis and Rheumatism|July 13, 2004
Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritisPetra Herrak, Birgit Görtz, Silvia Hayer, et al.
Arthritis Research & Therapy|January 12, 2005
JNK1 is not essential for TNF-mediated joint diseaseMarcus Köller, Silvia Hayer, Kurt Redlich, et al.
Rheumatology (Oxford, England)|August 11, 2006
Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of diseaseK P Machold, T A Stamm, V P K Nell, et al.
Arthritis and Rheumatism|October 2, 2007
Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health statusTanja A Stamm, Bettina Bauernfeind, Michaela Coenen, et al.
Pageof 147

Showing results (841-850 of 1,467) with videos related to

Sort By:
Pageof 147
Genes & Development|August 5, 2009
A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progressionMin Yu, Gromoslaw A Smolen, Jianmin Zhang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 1, 2007
Development, validation, and application of a microsimulation model to predict stroke and mortality in medically managed asymptomatic patients with significant carotid artery stenosisHarry J Smolen, David J Cohen, Gregory P Samsa, et al.
Molecular Pharmaceutics|March 21, 2013
In vivo gene delivery with L-tyrosine polyphosphate nanoparticlesAndrew J Ditto, John J Reho, Kush N Shah, et al.
Annals of the Rheumatic Diseases|May 21, 2008
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rateG Wells, J-C Becker, J Teng, et al.
The Journal of Investigative Dermatology|August 1, 1996
Immunoglobulin E response to human proteins in atopic patientsR Valenta, D Maurer, R Steiner, et al.
Journal of Proteome Research|October 6, 2022
A Parallelization Strategy for the Time Efficient Analysis of Thousands of LC/MS Runs in High-Performance Computing EnvironmentPatrick van Zalm, Arthur Viodé, Kinga Smolen, et al.
Arthritis and Rheumatism|July 13, 2004
Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritisPetra Herrak, Birgit Görtz, Silvia Hayer, et al.
Arthritis Research & Therapy|January 12, 2005
JNK1 is not essential for TNF-mediated joint diseaseMarcus Köller, Silvia Hayer, Kurt Redlich, et al.
Rheumatology (Oxford, England)|August 11, 2006
Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of diseaseK P Machold, T A Stamm, V P K Nell, et al.
Arthritis and Rheumatism|October 2, 2007
Concepts important to persons with systemic lupus erythematosus and their coverage by standard measures of disease activity and health statusTanja A Stamm, Bettina Bauernfeind, Michaela Coenen, et al.
Pageof 147